Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00043849. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary aim of this study is to determine the safety and efficacy of quetiapine (Seroquel) for the treatment of psychosis and/or agitation in patients with primary dementia complicated by coexistent parkinsonism, or patients with Parkinson's disease with dementia \[PDD\] who have episodes of agitation or psychosis. The secondary aim is to determine the safety and tolerability, particularly the influence on parkinsonism, of quetiapine when used to treat psychosis and/or agitation in patients with dementia complicated by coexistent parkinsonism.
Study identification
- NCT ID
- NCT00043849
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2002 (Type not available)
- Primary completion
- Jun 2005 (Actual)
- Completion
- Jun 2005 (Actual)
- Last update posted
- Dec 11, 2009
2002 – 2005
United States locations
- U.S. sites
- 21
- U.S. states
- 11
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham, Alzheimer's Disease Research Center | Birmingham | Alabama | 35233-0017 | — |
| University of California, San Diego, Alzheimer's Disease Center | La Jolla | California | 92037 | — |
| VA Healthcare System Long Beach | Long Beach | California | 90822 | — |
| University of California at Los Angeles, Alzheimer's Disease Center | Los Angeles | California | 90095-1769 | — |
| Stanford/VA Aging Clinical Research Center, Department of Psychiatry & Behavioral Sciences | Palo Alto | California | 94304 | — |
| Emory University, Alzheimer's Disease Center | Atlanta | Georgia | 30322 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Southern Illinois University, School of Medicine | Springfield | Illinois | 62702 | — |
| E. N. Rogers Memorial Veterans Hospital | Bedford | Massachusetts | 01730 | — |
| University of Nevada | Las Vegas | Nevada | 89102 | — |
| Parkinson's Disease and Movement Disorders Center, Albany Medical College | Albany | New York | 12205 | — |
| Maimonides Medical Center | Brooklyn | New York | 11219 | — |
| Columbia University, Alzheimer's Disease Research Center | New York | New York | 10032 | — |
| University of Rochester Medical Center, Alzheimer's Disease Center | Rochester | New York | 14620 | — |
| Syracuse VA Medical Center | Syracuse | New York | 13210 | — |
| University of Pittsburgh, Alzheimer's Disease Research Center | Pittsburgh | Pennsylvania | 15213-2593 | — |
| University of Texas Southwestern Medical Center at Dallas, Alzheimer's Disease Center | Dallas | Texas | 75390-9070 | — |
| Memory Clinic at Southwestern Vermont Medical Center | Bennington | Vermont | 05201 | — |
| Fletcher Allan Health Care, Inc. | Burlington | Vermont | 05401 | — |
| University of Washington at Seattle, Alzheimer's Disease Research Center | Seattle | Washington | 98108-1597 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00043849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 11, 2009 · Synced Nov 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.